A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes.
<h4>Background</h4>The single patient (n-of-1) trial can be used to resolve therapeutic uncertainty for the individual patient. Treatment alternatives are systematically tested against each other, generating patient-specific data used to inform an individualized treatment plan. We hypoth...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0269387&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540019652296704 |
|---|---|
| author | Joyce P Samuel Susan H Wootton Travis Holder Donald Molony |
| author_facet | Joyce P Samuel Susan H Wootton Travis Holder Donald Molony |
| author_sort | Joyce P Samuel |
| collection | DOAJ |
| description | <h4>Background</h4>The single patient (n-of-1) trial can be used to resolve therapeutic uncertainty for the individual patient. Treatment alternatives are systematically tested against each other, generating patient-specific data used to inform an individualized treatment plan. We hypothesize that clinical decisions informed by n-of-1 trials improve patient outcomes compared to usual care. Our objective was to provide an overview of the clinical trial evidence on the effect of n-of-1 trials on clinical outcomes.<h4>Methods</h4>A systematic search of medical databases, trial registries, and gray literature was performed to identify trials assessing clinical outcomes in a group of patients undergoing an n-of-1 trial compared to those receiving usual care for any clinical condition. We abstracted elements related to study design and results and assessed risk of bias for both the overall randomized trials and the n-of-1 trials. The review was registered on PROSPERO. (CRD: 42020166490).<h4>Findings</h4>Twelve randomized trials of the n-of-1 approach were identified in conditions spanning chronic pain, osteoarthritis, chronic irreversible airflow limitation, attention-deficit hyperactivity disorder, hyperlipidemia, atrial fibrillation, statin intolerance, and hypertension. One trial showed a statistically significant benefit in the primary outcome. Only one reached the pre-specified sample size target. Secondary outcomes showed modest benefits, including decreasing medication use, fewer atrial fibrillation episodes, and improved patient satisfaction.<h4>Interpretation</h4>Very few trials have been undertaken to assess the effectiveness of n-of-1 trials in improving clinical outcomes, and most trials were underpowered for the primary outcome. Barriers to enrollment and retention in these trials should be explored, as well-powered randomized trials are needed to clarify the clinical impact of n-of-1 trials and assess their utility in clinical practice. |
| format | Article |
| id | doaj-art-0f8dfd07e5d547a5b9c4f76d2c94f176 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-0f8dfd07e5d547a5b9c4f76d2c94f1762025-02-05T05:32:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01176e026938710.1371/journal.pone.0269387A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes.Joyce P SamuelSusan H WoottonTravis HolderDonald Molony<h4>Background</h4>The single patient (n-of-1) trial can be used to resolve therapeutic uncertainty for the individual patient. Treatment alternatives are systematically tested against each other, generating patient-specific data used to inform an individualized treatment plan. We hypothesize that clinical decisions informed by n-of-1 trials improve patient outcomes compared to usual care. Our objective was to provide an overview of the clinical trial evidence on the effect of n-of-1 trials on clinical outcomes.<h4>Methods</h4>A systematic search of medical databases, trial registries, and gray literature was performed to identify trials assessing clinical outcomes in a group of patients undergoing an n-of-1 trial compared to those receiving usual care for any clinical condition. We abstracted elements related to study design and results and assessed risk of bias for both the overall randomized trials and the n-of-1 trials. The review was registered on PROSPERO. (CRD: 42020166490).<h4>Findings</h4>Twelve randomized trials of the n-of-1 approach were identified in conditions spanning chronic pain, osteoarthritis, chronic irreversible airflow limitation, attention-deficit hyperactivity disorder, hyperlipidemia, atrial fibrillation, statin intolerance, and hypertension. One trial showed a statistically significant benefit in the primary outcome. Only one reached the pre-specified sample size target. Secondary outcomes showed modest benefits, including decreasing medication use, fewer atrial fibrillation episodes, and improved patient satisfaction.<h4>Interpretation</h4>Very few trials have been undertaken to assess the effectiveness of n-of-1 trials in improving clinical outcomes, and most trials were underpowered for the primary outcome. Barriers to enrollment and retention in these trials should be explored, as well-powered randomized trials are needed to clarify the clinical impact of n-of-1 trials and assess their utility in clinical practice.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0269387&type=printable |
| spellingShingle | Joyce P Samuel Susan H Wootton Travis Holder Donald Molony A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes. PLoS ONE |
| title | A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes. |
| title_full | A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes. |
| title_fullStr | A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes. |
| title_full_unstemmed | A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes. |
| title_short | A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes. |
| title_sort | scoping review of randomized trials assessing the impact of n of 1 trials on clinical outcomes |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0269387&type=printable |
| work_keys_str_mv | AT joycepsamuel ascopingreviewofrandomizedtrialsassessingtheimpactofnof1trialsonclinicaloutcomes AT susanhwootton ascopingreviewofrandomizedtrialsassessingtheimpactofnof1trialsonclinicaloutcomes AT travisholder ascopingreviewofrandomizedtrialsassessingtheimpactofnof1trialsonclinicaloutcomes AT donaldmolony ascopingreviewofrandomizedtrialsassessingtheimpactofnof1trialsonclinicaloutcomes AT joycepsamuel scopingreviewofrandomizedtrialsassessingtheimpactofnof1trialsonclinicaloutcomes AT susanhwootton scopingreviewofrandomizedtrialsassessingtheimpactofnof1trialsonclinicaloutcomes AT travisholder scopingreviewofrandomizedtrialsassessingtheimpactofnof1trialsonclinicaloutcomes AT donaldmolony scopingreviewofrandomizedtrialsassessingtheimpactofnof1trialsonclinicaloutcomes |